Estrogen deprivation and excess energy supply accelerate 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in C3H/HeN mice

키워드

참고문헌 (65)

1. Grossmann ME, "Obesity and breast cancer: status of leptin and adiponectin in pathological processes", Cancer Metastasis Rev, 29, pp.641~653 (2010)
2. Rohan TE, "Body fat and breast cancer risk in postmenopausal women: a longitudinal study", J Cancer Epidemiol, 2013, pp.754815~ (2013)
3. Calle EE, "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults", N Engl J Med, 348, pp.1625~1638 (2003)
4. Eliassen AH, "Adult weight change and risk of postmenopausal breast cancer", JAMA, 296, pp.193~201 (2006)
5. World Cancer Research Fund (GB), "Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective" (2007), American Institute for Cancer Research
6. World Cancer Research Fund International, Continuous Update Project (GB), "Diet, Nutrition, Physical Activity, and the Breast Cancer Survivors" (2014), World Cancer Research Fund International
7. Brennan SF, "Dietary fat and breast cancer mortality: a systematic review and meta-analysis", Crit Rev Food Sci Nutr (2015)
8. Mourouti N, "Diet and breast cancer: a systematic review", Int J Food Sci Nutr, 66, pp.1~42 (2015)
9. Demir B, "The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women", Gynecol Endocrinol, 24, pp.347~353 (2008)
10. Jensen LB, "Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study", J Bone Miner Res, 18, pp.333~342 (2003)
11. Cooke PS, "Role of estrogens in adipocyte development and function", Exp Biol Med (Maywood), 229, pp.1127~1135 (2004)
12. D'Eon TM, "Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways", J Biol Chem, 280, pp.35983~35991 (2005)
13. Field FJ, "Polyunsaturated fatty acids decrease the expression of sterol regulatory element-binding protein-1 in CaCo-2 cells: effect on fatty acid synthesis and triacylglycerol transport", Biochem J, 368, pp.855~864 (2002)
14. Horton JD, "Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis", Biochem Soc Trans, 30, pp.1091~1095 (2002)
15. Kuhl J, "Characterisation of subjects with early abnormalities of glucose tolerance in the Stockholm Diabetes Prevention Programme: the impact of sex and type 2 diabetes heredity", Diabetologia, 48, pp.35~40 (2005)
16. Macotela Y, "Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism", Diabetes, 58, pp.803~812 (2009)
17. Saengsirisuwan V, "Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement", Metabolism, 58, pp.38~47 (2009)
18. Gao H, "Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob", ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3, 2006, pp.20, 1287~1299
19. Vona-Davis L, "Adiposity, type 2diabetes and the metabolic syndrome in breast cancer", Obes Rev, 8, pp.395~408 (2007)
20. Jouyandeh Z, "Metabolic syndrome and menopause", J Diabetes Metab Disord, 12, pp.1~ (2013)
21. Frasca F, "The role of insulin receptors and IGF-I receptors in cancer and other diseases", Arch Physiol Biochem, 114, pp.23~37 (2008)
22. Kim HJ, "Effects and prooxidant mechanisms of oxidized alpha-tocopherol on the oxidative stability of soybean oil", J Food Sci, 72, pp.C223~C230 (2007)
23. Hong J, "Estrogen inhibits the effects of obesity and alcohol on mammary tumors and fatty liver", Int J Oncol, 39, pp.1443~1453 (2011)
24. Blume-Jensen P, "Oncogenic kinase signalling", Nature, 411, pp.355~365 (2001)
25. Reeves PG, "AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet", J Nutr, 123, pp.1939~1951 (1993)
26. Park SY, "Effects of diet-induced obesity on colitis-associated colon tumor formation in A", J mice, 2012, pp.36, 273~280
27. Stephenson GD, "Breast cancer and obesity: an update", Nutr Cancer, 45, pp.1~16 (2003)
28. Healy LA, "Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer", Clin Oncol (R Coll Radiol), 22, pp.281~288 (2010)
29. Nadal A, "The role of oestrogens in the adaptation of islets to insulin resistance", J Physiol, 587, pp.5031~5037 (2009)
30. Hong J, "Differential susceptibility to obesity between male, female and ovariectomized female mice", Nutr J, 8, pp.11~ (2009)
31. Hakkak R, "Obesity increases the incidence of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in an ovariectomized Zucker rat model", Int J Oncol, 30, pp.557~563 (2007)
32. Sylvester PW, "Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats", Cancer Res, 46, pp.763~769 (1986)
33. Costa I, "Histopathologic characterization of mammary neoplastic lesions induced with 7,12 dimethylbenz (alpha)anthracene in the rat: a comparative analysis with human breast tumors", Arch Pathol Lab Med, 126, pp.915~927 (2002)
34. Hwang IK, "Strain-specific differences in cell proliferation and differentiation in the dentate gyrus of C57BL", 6N and C3H, Brain Res, pp.2008, 1241[DOI]
35. Suganami T, "Attenuation of obesity-induced adipose tissue inflammation in C3H", HeJ mice carrying a Toll-like receptor 4 mutation, 2007, pp.354, 45~49
36. Lim DW, "Preventive effects of Citrus unshiu peel extracts on bone and lipid metabolism in OVX rats", Molecules, 19, pp.783~794 (2014)
37. Choi JS, "Genistein reduced insulin resistance index through modulating lipid metabolism in ovariectomized rats", Nutr Res, 32, pp.844~855 (2012)
38. Lane HW, "The effect of diet, exercise and 7,12-dimethylbenz(a)anthracene on food intake, body composition and carcass energy levels in virgin female BALB", c mice, 1991, pp.121, 1876~1882
39. Ojeswi BK, "Protective effect of Thuja occidentalis against DMBA-induced breast cancer with reference to oxidative stress", Hum Exp Toxicol, 29, pp.369~375 (2010)
40. Gambacciani M, "Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women", J Clin Endocrinol Metab, 82, pp.414~417 (1997)
41. Asp ML, "Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice", Int J Cancer, 126, pp.756~763 (2010)
42. Suba Z, "Circulatory estrogen level protects against breast cancer in obese women", Recent Pat Anticancer Drug Discov, 8, pp.154~167 (2013)
43. Koricanac G, "Insulin signaling in the liver and uterus of ovariectomized rats treated with estradiol", J Steroid Biochem Mol Biol, 108, pp.109~116 (2008)
44. Swislocki A, "Effects of ovariectomy on indices of insulin resistance, hypertension, and cardiac energy metabolism in middle-aged spontaneously hypertensive rats (SHR)", Horm Metab Res, 34, pp.516~522 (2002)
45. Carr MC, "The emergence of the metabolic syndrome with menopause", J Clin Endocrinol Metab, 88, pp.2404~2411 (2003)
46. Pfeilschifter J, "Changes in proinflammatory cytokine activity after menopause", Endocr Rev, 23, pp.90~119 (2002)
47. Gu JW, "Postmenopausal obesity promotes tumor angiogenesis and breast cancer progression in mice", Cancer Biol Ther, 11, pp.910~917 (2011)
48. Nunez NP, "Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones", Nutr Cancer, 60, pp.534~541 (2008)
49. Asselin J, "Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat", J Steroid Biochem, 9, pp.1079~1082 (1978)
50. Sasaki GH, "On the mechanism of hormone action in 7,12dimethylbenz(a)anthracene-induced mammary tumor. I. Prolactin and progesterone effects on estrogen receptor in vitro", Cancer, 35, pp.645~651 (1975)
51. Dao TL, "The role of ovarian hormones in initiating the induction of mammary cancer in rats by polynuclear hydrocarbons", Cancer Res, 22, pp.973~981 (1962)
52. Rose DP, "Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review)", Int J Oncol, 21, pp.1285~1292 (2002)
53. Daling JR, "Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma", Cancer, 92, pp.720~729 (2001)
54. Belfiore A, "IGF and insulin receptor signaling in breast cancer", J Mammary Gland Biol Neoplasia, 13, pp.381~406 (2008)
55. Wysocki PJ, "Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin", Expert Rev Mol Diagn, 10, pp.509~519 (2010)
56. Clark AS, "Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells", Mol Cancer Ther, 1, pp.707~717 (2002)
57. Woo SL, "Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity", PLoS One, 9, pp.e91111~ (2014)
58. Wohlers LM, "Changes in contraction-induced phosphorylation of AMPactivated protein kinase and mitogen-activated protein kinases in skeletal muscle after ovariectomy", J Cell Biochem, 107, pp.171~178 (2009)
59. Tiainen M, "Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1", CIP1), 2002, pp.11, 1497~1504
60. Jones RG, "AMP-activated protein kinase induces a p53-dependent metabolic checkpoint", Mol Cell, 18, pp.283~293 (2005)
61. Chapuis N, "Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies", Leukemia, 24, pp.1686~1699 (2010)
62. Kim JY, "17beta-estradiol induces an interaction between adenosine monophosphate-activated protein kinase and the insulin signaling pathway in 3T3-L1adipocytes", Int J Mol Med, 30, pp.979~985 (2012)
63. McInnes KJ, "Regulation of LKB1expression by sex hormones in adipocytes", Int J Obes (Lond), 36, pp.982~985 (2012)
64. Kim JY, "Parenteral 17beta-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy", Life Sci, 87, pp.358~366 (2010)
65. Mita MM, "The molecular target of rapamycin (mTOR) as a therapeutic target against cancer", Cancer Biol Ther, 2, pp.S169~S177 (2003)

관련 논문AI추천